Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(14%)
Results Posted
60%(3 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_4
1
14%
Ph phase_1
4
57%
Ph phase_3
1
14%
Ph phase_2
1
14%

Phase Distribution

4

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
4(57.1%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)

Detailed Status

Completed5
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (57.1%)
Phase 21 (14.3%)
Phase 31 (14.3%)
Phase 41 (14.3%)

Trials by Status

recruiting114%
terminated114%
completed571%

Recent Activity

1 active trials
Showing 5 of 7
recruitingphase_4

Relationship Between Different Administration Regimens of Ceftazidime/Avibactam and Clinical Outcomes

NCT06528028
completedphase_1

Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections

NCT01893346
completedphase_3

Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections

NCT01499290
completedphase_1

A Study to Investigate the Effect of Administration of Ceftazidime-avibactam (CAZ-AVI) and Ceftaroline Fosamil -Avibactam (CXL) on the Intestinal Flora of Healthy Volunteers

NCT01789528
completedphase_1

A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately

NCT01534247
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06528028Phase 4

Relationship Between Different Administration Regimens of Ceftazidime/Avibactam and Clinical Outcomes

Recruiting
NCT01893346Phase 1

Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections

Completed
NCT01499290Phase 3

Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections

Completed
NCT01789528Phase 1

A Study to Investigate the Effect of Administration of Ceftazidime-avibactam (CAZ-AVI) and Ceftaroline Fosamil -Avibactam (CXL) on the Intestinal Flora of Healthy Volunteers

Completed
NCT01534247Phase 1

A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately

Completed
NCT01920399Phase 1

A Phase I Study to Assess the Safety, Tolerability and PK of Ceftazidime-Avibactam in Healthy Chinese Subjects

Completed
NCT02732327Phase 2

Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer

Terminated

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7